Clincosm LogoSign in Get a demo

Essential Thrombocythemia

Showing 26 - 50 of 63
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Essential Thrombocythemia, Primary Myelofibrosis, Fibrotic Stage, Primary Myelofibrosis, Prefibrotic Stage Trial in Doha

Unknown status
  • Essential Thrombocythemia
  • +2 more
  • Diagnostic (18F-FLT PET/CT)
  • Doha, Qatar
    National Center for Cancer Care & Research (NCCCR)
Sep 27, 2020

Essential Thrombocythemia, Primary Myelofibrosis, Fibrotic Stage, Primary Myelofibrosis, Prefibrotic Stage Trial in Doha

Terminated
  • Essential Thrombocythemia
  • +3 more
  • Diagnostic (18F-FLT PET/CT)
  • Doha, Qatar
    National Center for Cancer Care & Research (NCCCR)
Aug 10, 2020

Endoplasmic Reticulum Stress and Resistance to Treatments in

Completed
  • Polycythemia Vera
  • Essential Thrombocythemia
  • RNA sample of total leukocytes before start of treatment
  • Angers, France
  • +6 more
Jun 18, 2020

Polycythemia Vera, Essential Thrombocythemia Trial in Worldwide (Momelotinib)

Terminated
  • Polycythemia Vera
  • Essential Thrombocythemia
  • Scottsdale, Arizona
  • +14 more
Apr 14, 2020

Primary Myelofibrosis, Thrombocytosis, Essential Thrombocythemia Trial in Worldwide (LDE225, INC424)

Completed
Has Results
  • Primary Myelofibrosis
  • +9 more
  • Camperdown, New South Wales, Australia
  • +17 more
Apr 3, 2020

Myeloproliferative Disorder, Myeloproliferative Syndrome, Myelofibrosis Trial in Irvine (USDA Diet, Mediterranean Diet)

Completed
  • Myeloproliferative Disorder
  • +4 more
  • USDA Diet
  • Mediterranean Diet
  • Irvine, California
    University of California, Irvine
Mar 23, 2020

Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome Trial in

Completed
Has Results
  • Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
  • +13 more
  • Salt Lake City, Utah
  • +2 more
Jan 15, 2020

Secondary Cancers in Myeloproliferative Neoplasms (MPN-K Study)

Completed
  • Polycythemia Vera
  • +2 more
  • JAK2V617F mutation
  • Olomouc, Czechia
  • +29 more
Dec 5, 2019

Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia:

Completed
  • Polycythemia Vera
  • +2 more
    • Salt Lake City, Utah
      University of Utah
    Oct 14, 2019

    Myeloproliferative Disorder, Essential Thrombocythemia, Primary Myelofibrosis, Prefibrotic Stage Trial in Angers, Brest

    Recruiting
    • Myeloproliferative Disorder
    • +3 more
    • Non-invasive diagnosis score
    • Angers, France
    • +1 more
    Sep 10, 2019

    Polycythemia Vera, Essential Thrombocythemia Trial in Washington, New York, Winston-Salem (RG7388, Pegasys)

    Completed
    • Polycythemia Vera
    • Essential Thrombocythemia
    • Washington, District of Columbia
    • +2 more
    Sep 11, 2019

    Research Tissue Bank

    Completed
    • Myelofibrosis
    • +3 more
      • Palo Alto, California
      • +10 more
      Jul 2, 2019

      Myeloproliferative Neoplastic Diseases Observatory From Brest

      Recruiting
      • Polycythemia Vera
      • +2 more
        • Brest, France
          CHRU de Brest
        Jun 27, 2019

        Myeloproliferative Tumor, Primary Myelofibrosis, Essential Thrombocythemia Trial in Switzerland (Mirabegron)

        Completed
        • Myeloproliferative Neoplasm
        • +3 more
        • Aarau, Switzerland
        • +10 more
        May 13, 2019

        Myeloproliferative Tumor, Unclassifiable, Essential Thrombocythemia, Myelofibrosis Trial in Herlev (CALRLong36 peptide)

        Unknown status
        • Myeloproliferative Neoplasm, Unclassifiable
        • +2 more
        • CALRLong36 peptide
        • Herlev, Capital Region, Denmark
          Herlev Hospital
        Feb 14, 2019

        Acute Myeloid Leukemia, Essential Thrombocythemia Trial in United States (LY573636-sodium)

        Completed
        Has Results
        • Acute Myeloid Leukemia
        • Essential Thrombocythemia
        • Los Angeles, California
        • +4 more
        Dec 16, 2018

        Patients With Myeloproliferative Disorders

        Completed
        • Myeloproliferative Disease
        • +4 more
          • Scottsdale, Arizona
          • +21 more
          Dec 12, 2018

          Cytoreductive Drugs in PV and ET Patients

          Completed
          • Polycythemia Vera
          • Essential Thrombocythemia
            • Brest, France
              CHRU de Brest
            Sep 20, 2018

            Polycythemia Vera or Essential Thrombocythemia Patients

            Completed
            • Polycythemia Vera
            • Essential Thrombocythemia
            • Blood specimen
            • New York, New York
              Icahn School of Medicine at Mount Sinai
            Jan 17, 2018

            Familial Myeloproliferative Disorders

            Completed
            • Polycythemia Vera
            • +2 more
              • Washington, D.C., District of Columbia
              • +5 more
              Sep 1, 2017

              MPN, Essential Thrombocythemia Trial in Creteil (Aspirin therapy interruption, Usual treatment by aspirin 100 mg/d in the active

              Recruiting
              • MPN
              • Essential Thrombocythemia
              • Aspirin therapy interruption
              • +3 more
              • Creteil, France
                Henri Mondor Hospital
              Jul 24, 2017

              Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission

              Completed
              Has Results
              • Accelerated Phase Chronic Myelogenous Leukemia
              • +178 more
              • fludarabine phosphate
              • +5 more
              • Seattle, Washington
                Fred Hutchinson Cancer Research Center/University of Washington
              Apr 17, 2017

              Myeloproliferative Tumors of, Polycythemia Vera, Essential Thrombocythemia Trial in United States (LY2784544)

              Completed
              • Myeloproliferative Neoplasms of
              • +3 more
              • Birmingham, Alabama
              • +8 more
              Apr 10, 2017

              Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute

              Completed
              • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
              • +22 more
              • therapeutic allogeneic lymphocytes
              • +10 more
              • Seattle, Washington
                Fred Hutchinson Cancer Research Center/University of Washington
              Mar 27, 2017

              Patients With Myeloproliferative Disorders

              Withdrawn
              • Myeloproliferative Disorders
              • +4 more
                • Jinan, Shandong, China
                  Qilu Hospital, Shandong University
                Apr 18, 2016